1.Effect of snail polypeptide on skin healing and expression of basic fibroblast growth factor mRNA in rats with scalded wound
Peng-Tao CAO ; Shi-Peng LI ; Lu-Lu ZHANG ; Pei-Zhe ZHANG ; Xiao-Han YUAN ; Jun-Ling AN ; Shou-Min XI
The Chinese Journal of Clinical Pharmacology 2015;(14):1426-1428
Objective To investigate effect of snail polypeptide on skin healing and expression of basic fibroblast growth factor ( bFGF) mRNA in rats with scalded wound.Methods The deepⅡscald model was estab-lished in 60 rats by using 90 ℃ hot water.And the rats were randomly divided into model group and the test group.Rat burn sites in test group were smeared with SP solution(10 mg? mL-1 ).Skin healing rate,skin healing time and the scab off time were observed in each group of rats. The mRNA expression of skin tissue bFGF was detected by RT-PCR. Results Healing rate of test group at different times after treatment were significantly higher than the model group, with statistically significant difference ( P <0.05 or P <0.01 ) .Compared with the model group, burn the skin healing time scab off times are significantly shorter in test group, the difference was statistically significant ( P <0.05 ) .Mean-while, SP increased the expression of bFGF mRNA at different times. Conclusion SP can promote wound healing in rat skin burns, and its mechanism may be related to regulating bFGF mRNA expression.
2. Effect of Cooling Blood Method in Inhibiting Macrophage Apoptosis Against Atherosclerosis
Xue-qian LIU ; Jing WANG ; Shou-pei CAO ; Yao-hong SONG
Chinese Journal of Experimental Traditional Medical Formulae 2019;25(3):59-65
Objective: To observe the effect of serum-containing Qingxin Tongmai decoction(QXTMD) on the apoptosis rate of mouse mononuclear macrophage cell line RAW264.7 induced by Acetylated low density lipoprotein (ac-LDL) and the expressions of type A scavenger receptor(SR-A), B-cell lymphoma-2(Bcl-2), Bcl-2-associated X protein(Bax), inositol-requiring enzyme 1α(IRE1α), exploring the possible mechanism of QXTMD in the treatment of atherosclerosis.Method: Eight New Zealand rabbits were randomly divided into the atorvastatin group (2.6 g·kg-1) low, medium and high-dose QXTMD groups (3.33, 6.66, 13.32 mg·kg-1). After 7 days of gavage, the carotid blood was collected to prepare drug-containing serum. The RAW264.7 cell line was stimulated with 2.5%, 5%, 10%, and 20% drug-containing serum culture for 6, 12, and 24 h, respectively. The cell proliferation rate was observed by cell counting kit-8 (CCK-8) method. The RAW264.7 cell line was cultured in vitro and divided into blank group, model group, atorvastatin group, and low, medium and high-dose QXTMY groups. The cells in blank group were cultured with bovine serum albumin(BSA). The model group was stimulated with BSA+50 mg·L-1 ac-LDL for 24 h. The other groups were stimulated with BSA+50 mg·L-1 ac-LDL+10% drug-containing serum for 24 h. The apoptosis rate and SR-A expression of RAW264.7 cells were detected by flow cytometry. The expressions of Bcl-2, Bax and IRE1α protein were detected by Western blot.Result: Compared with the blank group, the model group could increase the apoptosis rate of RAW264.7 cells (P<0.01) and the expressions of Bax and SR-A protein (P<0.01), but decrease the expression of Bcl-2 protein (P<0.05). Compared with the model group, low, medium and high-dose QXTMD groups could decrease the apoptosis rate of RAW264.7 cell line (P<0.05) and the expressions of SR-A and IRE1α (P<0.05,P<0.01). The low-dose QXTMD group and the high-dose QXTMD group could decrease the expression of Bax(P<0.05,P<0.01). The middle-dose group and the high-dose group could decrease the expression of Bcl-2(P<0.01).Conclusion: QXTMD can reduce the apoptosis rate of macrophages. The mechanism of atherosclerosis may be related to the expressions of Bax, IREα, SR-A and anti-apoptotic protein Bcl-2.
3.Medical expenditure for esophageal cancer in China: a 10-year multicenter retrospective survey (2002–2011)
Guo LAN-WEI ; Huang HUI-YAO ; Shi JU-FANG ; Lv LI-HONG ; Bai YA-NA ; Mao A-YAN ; Liao XIAN-ZHEN ; Liu GUO-XIANG ; Ren JIAN-SONG ; Sun XIAO-JIE ; Zhu XIN-YU ; Zhou JIN-YI ; Gong JI-YONG ; Zhou QI ; Zhu LIN ; Liu YU-QIN ; Song BING-BING ; Du LING-BIN ; Xing XIAO-JING ; Lou PEI-AN ; Sun XIAO-HUA ; Qi XIAO ; Wu SHOU-LING ; Cao RONG ; Lan LI ; Ren YING ; Zhang KAI ; He JIE ; Zhang JIAN-GONG ; Dai MIN
Chinese Journal of Cancer 2017;36(11):548-559
Background: Esophageal cancer is associated with substantial disease burden in China, and data on the economic burden are fundamental for setting priorities in cancer interventions. The medical expenditure for the diagnosis and treatment of esophageal cancer in China has not been fully quantified. This study aimed to examine the medical expenditure of Chinese patients with esophageal cancer and the associated trends. Methods: From 2012 to 2014, a hospital-based multicenter retrospective survey was conducted in 37 hospitals in 13 provinces/municipalities across China as a part of the Cancer Screening Program of Urban China. For each esophageal cancer patient diagnosed between 2002 and 2011, clinical information and expense data were extracted by using structured questionnaires. All expense data were reported in Chinese Yuan (CNY; 1 CNY= 0.155 USD) based on the 2011 value and inflated using the year-specific health care consumer price index for China. Results: A total of 14,967 esophageal cancer patients were included in the analysis. It was estimated that the overall average expenditure per patient was 38,666 CNY, and an average annual increase of 6.27% was observed from 2002 (25,111 CNY) to 2011 (46,124 CNY). The average expenditures were 34,460 CNY for stage Ⅰ, 39,302 CNY for stage Ⅱ, 40,353 CNY for stage Ⅲ, and 37,432 CNY for stage IV diseases (P < 0.01). The expenditure also differed by the therapy type, which was 38,492 CNY for surgery, 27,933 CNY for radiotherapy, and 27,805 CNY for chemotherapy (P < 0.05). Drugs contributed to 45.02% of the overall expenditure. Conclusions: These conservative estimates suggested that medical expenditures for esophageal cancer in China substantially increased in the last 10 years, treatment for early-stage esophageal cancer costs less than that for advanced cases, and spending on drugs continued to account for a considerable proportion of the overall expenditure.
4.Analysis of intestinal microbial diversity in Leopoldamys edwardsi based on illumina sequencing technique.
Duan Duan XUAN ; Yuan Li LI ; Guan Nan ZHANG ; Lin Wei DING ; Pei Pei CAO ; Rui Jie JIA ; Yu Ai ZHENG ; Xiao Jun ZHOU ; Liang Yuan PAN ; Shou Kui HU ; Li Na NIU
Chinese Journal of Preventive Medicine 2022;56(4):512-518
To explore the composition and diversity of the intestinal microflora of Leopoldamys edwardsi in Hainan Island. In November 2019, DNA was extracted from fecal samples of 25 adult Leopoldamys edwardsi (14 males and 11 females) in Hainan Island at the Joint Laboratory of tropical infectious diseases of Hainan Medical College and Hong Kong University. Based on the IonS5TMXL sequencing platform, single-end sequencing (Single-End) was used to construct a small fragment library for single-end sequencing. Based on Reads shear filtration and OTUs clustering. The species annotation and abundance analysis of OTUs were carried out by using mothur method and SSUrRNA database, and further conducted α diversity and β diversity analysis. A total of 1481842 high quality sequences, belonging to 14 Phyla, 85 families and 186 Genera, were obtained from 25 intestinal excrement samples of Leopoldamys edwardsi. At the level of phyla classification, the main core biota of the Leopoldamys edwardsi contained Firmicutes (46.04%),Bacteroidetes (25.34%), Proteobacteria (17.09%), Tenericutes (7.38%) and Actinobacteria (1.67%), these five phyla account for 97.52% of all phyla. The ratio of Helicobacter which occupied the largest proportion at the genus level was 12.44%, followed by Lactobacillus (11.39%), Clostridium (6.19%),Mycoplasma (4.23%) and Flavonifractor (3.52%). High throughput sequencing analysis showed that the intestinal flora of Leopoldamys edwardsi in Hainan Island was complex and diverse, which had the significance of further research.
Adult
;
Animals
;
Bacteria/genetics*
;
Feces/microbiology*
;
Female
;
Gastrointestinal Microbiome/genetics*
;
High-Throughput Nucleotide Sequencing
;
Humans
;
Intestines
;
Male
;
Murinae/genetics*